A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer
Clinical trial NCT04690855 · TERMINATED
Trial details
- NCT number
- NCT04690855
- Sponsor
- Mylin A. Torres, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-04
- Primary completion
- 2022-02-18
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.